347 related articles for article (PubMed ID: 9776086)
1. Regeneration and myogenic cell proliferation correlate with taurine levels in dystrophin- and MyoD-deficient muscles.
McIntosh LM; Garrett KL; Megeney L; Rudnicki MA; Anderson JE
Anat Rec; 1998 Oct; 252(2):311-24. PubMed ID: 9776086
[TBL] [Abstract][Full Text] [Related]
2. Expression rate of myogenic regulatory factors and muscle growth factor after botulinum toxin A injection in the right masseter muscle of dystrophin deficient (mdx) mice.
Botzenhart UU; Gerlach R; Gredes T; Rentzsch I; Gedrange T; Kunert-Keil C
Adv Clin Exp Med; 2019 Jan; 28(1):11-18. PubMed ID: 30085421
[TBL] [Abstract][Full Text] [Related]
3. In situ hybridization analysis for expression of myogenic regulatory factors in regenerating muscle of mdx mouse.
Bhagavati S; Ghatpande A; Shafiq SA; Leung B
J Neuropathol Exp Neurol; 1996 May; 55(5):509-14. PubMed ID: 8627340
[TBL] [Abstract][Full Text] [Related]
4. The expression of myogenic regulatory factors and muscle growth factors in the masticatory muscles of dystrophin-deficient (mdx) mice.
Spassov A; Gredes T; Gedrange T; Lucke S; Pavlovic D; Kunert-Keil C
Cell Mol Biol Lett; 2011 Jun; 16(2):214-25. PubMed ID: 21327869
[TBL] [Abstract][Full Text] [Related]
5. Severe cardiomyopathy in mice lacking dystrophin and MyoD.
Megeney LA; Kablar B; Perry RL; Ying C; May L; Rudnicki MA
Proc Natl Acad Sci U S A; 1999 Jan; 96(1):220-5. PubMed ID: 9874799
[TBL] [Abstract][Full Text] [Related]
6. MyoD is required for myogenic stem cell function in adult skeletal muscle.
Megeney LA; Kablar B; Garrett K; Anderson JE; Rudnicki MA
Genes Dev; 1996 May; 10(10):1173-83. PubMed ID: 8675005
[TBL] [Abstract][Full Text] [Related]
7. Expression of MyoD and myogenin in dystrophic mice, mdx and dy, during regeneration.
Jin Y; Murakami N; Saito Y; Goto Y; Koishi K; Nonaka I
Acta Neuropathol; 2000 Jun; 99(6):619-27. PubMed ID: 10867795
[TBL] [Abstract][Full Text] [Related]
8. Nuclear magnetic resonance spectroscopy study of muscle growth, mdx dystrophy and glucocorticoid treatments: correlation with repair.
McIntosh L; Granberg KE; Brière KM; Anderson JE
NMR Biomed; 1998 Feb; 11(1):1-10. PubMed ID: 9608583
[TBL] [Abstract][Full Text] [Related]
9. Correlated NOS-Imu and myf5 expression by satellite cells in mdx mouse muscle regeneration during NOS manipulation and deflazacort treatment.
Anderson JE; Vargas C
Neuromuscul Disord; 2003 Jun; 13(5):388-96. PubMed ID: 12798794
[TBL] [Abstract][Full Text] [Related]
10. A significant reduction of the diaphragm in mdx:MyoD-/-(9th) embryos suggests a role for MyoD in the diaphragm development.
Inanlou MR; Dhillon GS; Belliveau AC; Reid GA; Ying C; Rudnicki MA; Kablar B
Dev Biol; 2003 Sep; 261(2):324-36. PubMed ID: 14499644
[TBL] [Abstract][Full Text] [Related]
11. Unacylated Ghrelin Enhances Satellite Cell Function and Relieves the Dystrophic Phenotype in Duchenne Muscular Dystrophy mdx Model.
Reano S; Angelino E; Ferrara M; Malacarne V; Sustova H; Sabry O; Agosti E; Clerici S; Ruozi G; Zentilin L; Prodam F; Geuna S; Giacca M; Graziani A; Filigheddu N
Stem Cells; 2017 Jul; 35(7):1733-1746. PubMed ID: 28436144
[TBL] [Abstract][Full Text] [Related]
12. Levels of MyoD protein expression following injury of mdx and normal limb muscle are modified by thyroid hormone.
Anderson JE; McIntosh LM; Moor AN; Yablonka-Reuveni Z
J Histochem Cytochem; 1998 Jan; 46(1):59-67. PubMed ID: 9407021
[TBL] [Abstract][Full Text] [Related]
13. Chronic exercise accelerates the degeneration-regeneration cycle and downregulates insulin-like growth factor-1 in muscle of mdx mice.
Okano T; Yoshida K; Nakamura A; Sasazawa F; Oide T; Takeda S; Ikeda S
Muscle Nerve; 2005 Aug; 32(2):191-9. PubMed ID: 15937872
[TBL] [Abstract][Full Text] [Related]
14. Hypothyroidism prolongs and increases mdx muscle precursor proliferation and delays myotube formation in normal and dystrophic limb muscle.
McIntosh LM; Anderson JE
Biochem Cell Biol; 1995; 73(3-4):181-90. PubMed ID: 7576492
[TBL] [Abstract][Full Text] [Related]
15. Extraocular muscle satellite cells are high performance myo-engines retaining efficient regenerative capacity in dystrophin deficiency.
Stuelsatz P; Shearer A; Li Y; Muir LA; Ieronimakis N; Shen QW; Kirillova I; Yablonka-Reuveni Z
Dev Biol; 2015 Jan; 397(1):31-44. PubMed ID: 25236433
[TBL] [Abstract][Full Text] [Related]
16. Expression profiling in stably regenerating skeletal muscle of dystrophin-deficient mdx mice.
Boer JM; de Meijer EJ; Mank EM; van Ommen GB; den Dunnen JT
Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S118-24. PubMed ID: 12206806
[TBL] [Abstract][Full Text] [Related]
17. Muscle function and running activity in mouse models of hereditary muscle dystrophy: impact of double knockout for dystrophin and the transcription factor MyoD.
Mangner N; Adams V; Sandri M; Hoellriegel R; Hambrecht R; Schuler G; Gielen S
Muscle Nerve; 2012 Apr; 45(4):544-51. PubMed ID: 22431088
[TBL] [Abstract][Full Text] [Related]
18. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
19. PDGF-receptor concentration is elevated in regenerative muscle fibers in dystrophin-deficient muscle.
Tidball JG; Spencer MJ; St Pierre BA
Exp Cell Res; 1992 Nov; 203(1):141-9. PubMed ID: 1426037
[TBL] [Abstract][Full Text] [Related]
20. Expression patterns of regulatory RNAs, including lncRNAs and tRNAs, during postnatal growth of normal and dystrophic (mdx) mouse muscles, and their response to taurine treatment.
Butchart LC; Terrill JR; Rossetti G; White R; Filipovska A; Grounds MD
Int J Biochem Cell Biol; 2018 Jun; 99():52-63. PubMed ID: 29578051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
